ZURA
Zura Bio Limited- Healthcare
- Biotechnology
- $322M market cap
Forecast run · Oct 29, 2026Upside rank 510 of 3,186
Model Signal
ForecastQ Daily Probabilities
45.0%
69.0%
41.9%
Analyst Consensus
Recommendation2.00/5 Buy
Last price$3.36
Price target$20.00
Implied move+495.2%
Analysts8
ForecastQ Portfolios
ZURA is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.